Clinical Trials for CASI Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CASI Pharmaceuticals

Clinical Trials (1)

NCT07017725
A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia
PHASE1/PHASE2Recruiting
75 participants
Started: Jan 3, 2025 · Completed: Dec 30, 2026
1 condition1 sponsor6 locations